🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A randomized comparison of glyburide to glucovance (metformin -glyburide) i...
Status
Terminated
Location
TTUHSC El Paso
Start Date
2016-07
Trial ID
NCT02726490
Treatments Being Tested
To evaluate the efficacy and safety of type 2 diabetes patients switched fr...
Status
Completed
Location
National Taiwan university hospital
Start Date
2006-05
Trial ID
NCT00541437
The goal of this clinical trial is to compare blood-sugar control and blood...
Status
Unknown
Location
Multiple Locations
Start Date
2023-08
Trial ID
NCT05688332
Treatments Being Tested
Type 2 diabetes is a systemic metabolic disease with significant morbidity ...
Status
Completed
Location
Texas Diabetes Institute
Start Date
2009-01
Trial ID
NCT01107717
Treatments Being Tested
This was a 10-week, placebo-controlled, randomized study to investigate the...
Status
Completed
Location
National Research Institute
Start Date
2010-02
Trial ID
NCT01068860
Treatments Being Tested
The purpose of this trial is to understand if adding saxagliptin to a sulfo...
Status
Completed
Location
Reserach Solutions, Llc
Start Date
2006-04
Trial ID
NCT00313313
Treatments Being Tested
This is a pharmacokinetic and pharmacodynamic study evaluating glyburide, m...
Status
Completed
Location
Indiana University School of Medicine
Start Date
2011-07
Trial ID
NCT01329016
Treatments Being Tested
The purpose of this trial is to investigate the use of metformin in the tre...
Status
Unknown
Location
Rowan University School of Osteopathic Medicine
Start Date
2019-10-29
Trial ID
NCT04141163
Treatments Being Tested
The purpose of this study is to determine whether incretin-based drugs (use...
Status
Completed
Location
Lady Davis Institute for Medical Research, Jewish General Hospital
Start Date
2014-03
Trial ID
NCT02476760
This study is a phase 3b, multicentre, randomised, open label, parallel gro...
Status
Completed
Location
GSK Investigational Site
Start Date
2001-04
Trial ID
NCT00379769
Treatments Being Tested